Please login to the form below

Not currently logged in
Email:
Password:

clazakizumab

This page shows the latest clazakizumab news and features for those working in and with pharma, biotech and healthcare.

Sanofi's sarilumab beats Humira in head-to-head trial

Sanofi's sarilumab beats Humira in head-to-head trial

Other companies developing IL-6 inhibitors for RA include GlaxoSmithKline (GSK) and Janssen, whose sirukumab candidate is scheduled for filing later this year, and Alder Bio Pharmaceuticals which has clazakizumab in

Latest news

  • Positive data for BMS’ clazakizumab in arthritis Positive data for BMS’ clazakizumab in arthritis

    Bristol-Myers Squibb (BMS) could be adding another drug to its rheumatoid arthritis (RA) franchise after reporting encouraging phase IIb data on clazakizumab this week. ... Clazakizumab … provides promising remission data that will need to be further

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....